Newsroom
Sorted by: Latest
-
Deutsche Bank AG UK Regulatory Announcement: FRN Variable Rate Fix
LONDON--(BUSINESS WIRE)-- ISIN Code. XS2747638257 Our Ref. MQ4915 ISSUE NAME. Santander UK PLC Issue of GBP 1,250,000,000.00 Floating rate covered bond due July 2027 Series 84 Tranche 1 MTN INTEREST PERIOD. 13/10/2025 TO 12/01/2026 VALUE DATE. 12/01/2026 INTEREST RATE. 4.4803 PCT NUM OF DAYS. 91 DAY BASIS. ACTUAL/365 FIXED (A005) CURRENCY CODE. GBP TOTAL INTEREST AMT. GBP 13,962,578.77 POOL FACTOR. N/A...
-
Deutsche Bank AG UK Regulatory Announcement: FRN Variable Rate Fix
LONDON--(BUSINESS WIRE)-- ISIN Code. XS2574480708 Our Ref. MP2432 ISSUE NAME. Santander UK PLC Issue of GBP 1,500,000,000.00 Floating Rate Covered Bonds due Jan 2028 Series 80 Tranche 1 MTN INTEREST PERIOD. 13/10/2025 TO 12/01/2026 VALUE DATE. 12/01/2026 INTEREST RATE. 4.5903 PCT NUM OF DAYS. 91 DAY BASIS. ACTUAL/365 FIXED (A005) CURRENCY CODE. GBP TOTAL INTEREST AMT. GBP 17,166,464.38 POOL FACTOR. N/A...
-
Deutsche Bank AG UK Regulatory Announcement: FRN Variable Rate Fix
LONDON--(BUSINESS WIRE)-- ISIN Code. XS3201118976 Our Ref. MU5775 ISSUE NAME. City of Stockholm Issue of SEK 1,000,000,000.00 Floating Rate Notes due January 2031 Series No 113 Tranche 1 MTN INTEREST PERIOD. 08/01/2026 TO 08/04/2026 VALUE DATE. 08/04/2026 INTEREST RATE. 2.255 PCT NUM OF DAYS. 90 DAY BASIS. Actual/360 (A004) CURRENCY CODE. SEK TOTAL INTEREST AMT. SEK 5,637,500 POOL FACTOR. N/A...
-
RoslinCT and BOOST Pharma Announce Strategic Manufacturing Agreement to Advance Cell Therapy for Infants with Osteogenesis Imperfecta
EDINBURGH, Scotland--(BUSINESS WIRE)--RoslinCT, a global contract development and manufacturing organization (CDMO) specializing in advanced cell therapies, and BOOST Pharma, a clinical-stage biotechnology company developing first-in-class cell therapies for rare paediatric skeletal diseases, today announced a strategic manufacturing partnership to support the development of BOOST Pharma’s cell therapy, BT-101, for the treatment of infants with Osteogenesis Imperfecta (OI), also known as brittl...
-
I Squared Capital Acquires Ramudden Global, a Leader in Traffic Management and Infrastructure Safety
MIAMI--(BUSINESS WIRE)--I Squared Capital, a leading global infrastructure investment manager, today announced that, through its flagship fund, it has agreed to acquire Ramudden Global, from funds advised by Triton Partners (“Triton”), a leading European mid-market sector-specialist investor. Ramudden Global is a leading international provider of traffic management and infrastructure safety services supporting the maintenance and upgrade of essential transport and utility networks. The company...
-
Aspect annonce une transition à la direction générale et la création d’un nouveau conseil d’administration indépendant
DENVER--(BUSINESS WIRE)--Aspect, l’un des principaux fournisseurs de solutions cloud de gestion des effectifs, a annoncé une transition à la direction générale, avec la nomination de Jeff Kupietzky au poste de directeur général par intérim et la création d’un nouveau conseil d’administration indépendant, marquant ainsi une nouvelle étape importante pour l’entreprise. Dans le cadre de cette transition, Darryl Kelly quittera son poste de directeur général et occupera désormais le poste de conseil...
-
Daiichi Sankyo and GENESIS Pharma Enter Exclusive Agreement for VANFLYTA® Commercialization in Central and Eastern Europe
MUNICH--(BUSINESS WIRE)--Daiichi Sankyo and GENESIS Pharma Enter Exclusive Agreement for VANFLYTA® Commercialization in Central and Eastern Europe...
-
Riassunto: Aspect annuncia una transizione nell’alta dirigenza aziendale e la costituzione di un nuovo consiglio di amministrazione indipendente
DENVER--(BUSINESS WIRE)--Aspect, un leader nello sviluppo di soluzioni cloud per la gestione della forza lavoro, ha annunciato un avvicendamento alla guida dell’azienda, che prevede la nomina di Jeff Kupietzky ad amministratore delegato ad interim e la costituzione di un nuovo consiglio di amministrazione indipendente, segnando così l’inizio di una nuova fase di sviluppo per la società. Nel quadro di questa transizione Darryl Kelly lascerà la carica di amministratore delegato per assumere il ru...
-
Thales助力Samsung Electronics打造荣获CES*大奖的后量子芯片
默东,法国--(BUSINESS WIRE)--(美国商业资讯)-- 量子计算机凭借其前所未有的运算能力,终将挑战当今的加密标准。正因如此,Thales对Samsung Electronics旗下System LSI事业部发布的全新后量子安全芯片获得CES 2026大奖表示欢迎——该芯片集成了Thales安全操作系统及抗量子加密库。这一技术突破标志着我们在保护联网设备方面迈出了重要一步,使其既能抵御当前网络攻击,也能应对未来量子时代的威胁。 Thales的强化操作系统使Samsung获奖安全芯片能够从设备开机瞬间起提供基于硬件的抗量子防护。该系统最终确保加密数据和设备凭证在面对经典攻击与量子攻击时均保持安全,即使在后量子时代也能确保机密性、完整性及长期信任。 这种威胁并非仅存在于未来:恶意攻击者现在就已经能够截获并存储加密数据,静待量子计算技术成熟后再进行解密。(“先窃取,后解密”)。随着量子计算实现预期的强大算力,当前安全标准所保护的一切——无论是个人身份信息、敏感凭证,还是嵌入联网设备的加密密钥——都将面临暴露风险。 Thales的操作系统与后量子加密库使Samsung芯片能够以低...
-
Thales為Samsung Electronics榮獲CES*大獎的後量子晶片提供技術支援
法國默東--(BUSINESS WIRE)--(美國商業資訊)-- 憑藉前所未見的運算能力,量子電腦終將對當下的加密標準構成挑戰。正因如此,Thales對Samsung Electronics旗下系統大型積體電路(System LSI)事業部推出的這款全新後量子就緒安全晶片榮獲CES 2026大獎表示祝賀,該晶片內嵌了Thales的安全作業系統和抗量子密碼編譯程式庫。這項突破性成果代表在保護聯網裝置抵禦現有網路攻擊和未來量子時代威脅的道路上邁出了關鍵一步。 Thales的加固型作業系統使Samsung的這款得獎安全晶片從裝置開機的那一刻起,就能提供以硬體為基礎的抗量子防護。最終,該晶片可確保加密資料和裝置憑證免受傳統攻擊和量子攻擊的威脅,即便在量子時代全面來臨後,也能保障機密性、完整性和長期可信度。 這種威脅並非只存在于未來:惡意攻擊者如今已能攔截並儲存加密資料,靜待量子運算技術成熟後再進行解密,即「現在竊取、日後解密」(harvest now, decrypt later)。事實上,憑藉量子運算的預期算力,任何採用現有加密標準保護的資料(包括個人身分資訊、敏感憑證,甚至內嵌在聯網裝置...